Skip to content

News

Search results for: Thairm

Pneumagen commits to clinical trial development for Covid-19

Pneumagen (Holdings) Ltd announced a £4m investment for the clinical development of Neumifil for the prevention and treatment of Covid-19.

27 May 2020Covid-19